Cites del registre
Cita APA (7th ed.)
Olgun, N., Cecen, E., Ince, D., Kizmazoglu, D., Baysal, B., Onal, A., . . . Aktas, S. (2022). Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience. Frontiers Media S.A.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Olgun, Nur, et al. Dinutuximab Beta Plus Conventional Chemotherapy for Relapsed/refractory High-risk Neuroblastoma: A Single-center Experience. Frontiers Media S.A, 2022.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Olgun, Nur, et al. Dinutuximab Beta Plus Conventional Chemotherapy for Relapsed/refractory High-risk Neuroblastoma: A Single-center Experience. Frontiers Media S.A, 2022.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.